DMD and Duchenne muscular dystrophy: Inflammatory events secondary to lack of dystrophin play a major role in the outcome of DMD pathology [2], [3], so that antiinflammatory steroids represents the current standard treatment for DMD patients, albeit with limited efficacy and undesired side effects [4], [5], [6].